BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8547151)

  • 1. Heterogenous inhibition of platelet aggregation by monoclonal antibodies binding to multiple sites on GPIIIa.
    Liu LX; Nardi MA; Nierodzik ML; Karpatkin S
    Br J Haematol; 1995 Dec; 91(4):976-82. PubMed ID: 8547151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
    Nakatanl S; Hato T; Minamoto Y; Fujita S
    Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific cross-reaction of IgG anti-phospholipid antibody with platelet glycoprotein IIIa.
    Tokita S; Arai M; Yamamoto N; Katagiri Y; Tanoue K; Igarashi K; Umeda M; Inoue K
    Thromb Haemost; 1996 Jan; 75(1):168-74. PubMed ID: 8713797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibrin(ogen) binding to stimulated platelets by a monoclonal antibody specific for a conformational determinant of GPIIIa.
    Ramsamooj P; Doellgast GJ; Hantgan RR
    Thromb Res; 1990 Jun; 58(6):577-92. PubMed ID: 2385828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
    Niewiarowska J; Cierniewski CS
    Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal antibody epitopes and the putative fibrinogen-binding sites.
    Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; González-Rodríguez J
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):457-63. PubMed ID: 1706596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation.
    Clark EA; Trikha M; Markland FS; Brugge JS
    J Biol Chem; 1994 Sep; 269(35):21940-3. PubMed ID: 7520909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
    Pidard D; Frelinger AL; Bouillot C; Nurden AT
    Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium ions and the conformation of glycoprotein IIIa that is essential fibrinogen binding to platelets: analysis by a new monoclonal anti-GP IIIa antibody, TM83.
    Yamamoto N; Kitagawa H; Yamamoto K; Tanoue K; Yamazaki H
    Blood; 1989 May; 73(6):1552-60. PubMed ID: 2469495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets.
    Khaspekova SG; Vlasik TN; Byzova TV; Vinogradov DV; Berndt MC; Mazurov AV
    Br J Haematol; 1993 Oct; 85(2):332-40. PubMed ID: 7506568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.
    Goodall AH; Curzen N; Panesar M; Hurd C; Knight CJ; Ouwehand WH; Fox KM
    Eur Heart J; 1999 May; 20(10):742-7. PubMed ID: 10329065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
    Okuda D; Morita T
    J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.